But in the long term, they're still bad businesses, and you end up with entire industries that are dysfunctional. Eventually, someone else eats your lunch.
In fact you can argue that's happening now, as the article hints: Zuck was able to assimilate Whatsapp and IG into his bloated empire, but he can't buy TikTok and its 500M users because it's from China. Maybe if FB has been forced to actually compete with its biggest American competitors instead of getting the greenlight from regulators to just buy them, it would be in a better position now.
The same business can look good or bad depending on your perspective. Mylan is a great business from its shareholders perspective and a bad business from everyone else's, because it gouges consumers by charging $600 for some that costs ~$15.
Sanofi made AuviQ (EpiPen clone) but pulled out after regulators made Sanofi do a full-scale recall after several injector faults. Teva was set to provide its own generic version, but in the final stages of the review process, it was rejected by the FDA.
The solution was to create policy (and to punish Mylan for breaking policy that already existed). Conducting an antitrust break-up of Mylan would have only made things worse imo.